The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
Official Title: Determinants of Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
Study ID: NCT05071677
Brief Summary: This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information sources that support this decision-making process.
Detailed Description: PRIMARY OBJECTIVE: I. Evaluate the acceptance of treatment recommendations by African American women diagnosed with triple negative breast cancer (TNBC). SECONDARY OBJECTIVES: I. Evaluate the association of beliefs about chemotherapy, self-efficacy, and cancer-specific psychological distress with intention to follow through with treatment. II. Evaluate the association of intention, Reliance on Formal or Informal Resources, and decisional conflict as predictors of final treatment decision. III. Evaluate the association of Reliance on Formal or Informal Resources as a moderator of the relationship between intention and final treatment decision. OUTLINE: Patients participate in a standard of care treatment planning meeting over 3 hours with members of the multidisciplinary treatment team including, the oncologist, radiologist, oncology surgeon, and social worker. Patients then complete surveys over 20 minutes and within 30 days later. Some patients may participate in interviews over 30 minutes.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
M D Anderson Cancer Center, Houston, Texas, United States
Name: Makesha V Miggins, MD
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR